Helsinki South Vaccine Research Clinic

Helsinki 00100

0 studies enrolling now · 4 studies all time

What they study most

Healthy, Hepatitis B Vaccines, Meningococcal Vaccine, Respiratory Syncytial Virus

Studies at this site

• A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed
• A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age. — Completed
• Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults — Completed
• A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years. — Completed